dopetalk does not endorse any advertised product nor does it accept any liability for it's use or misuse

This website has run out of funding so feel free to contribute if you can afford it (see footer)

Author Topic: Assessment of Abuse Potential of Drugs  (Read 7417 times)

Offline Chip (OP)

  • Server Admin
  • Hero Member
  • *****
  • Administrator
  • *****
  • Join Date: Dec 2014
  • Location: Australia
  • Posts: 6648
  • Reputation Power: 0
  • Chip has hidden their reputation power
  • Gender: Male
  • Last Login:Today at 11:22:15 AM
  • Deeply Confused Learner
  • Profession: IT Engineer
Assessment of Abuse Potential of Drugs
« on: August 04, 2015, 12:54:53 PM »
Contains Nonbinding Recommendations. Draft – Not for Implementation

1 Guidance for Industry1
2 Assessment of Abuse Potential of Drugs
6 This draft guidance, when finalized, will represent the Food and Drug Administration’s (FDA’s) current
7 thinking on this topic. It does not create or confer any rights for or on any person and does not operate to
8 bind the FDA or the public. You can use an alternative approach if the approach satisfies the
9 requirements of the applicable statutes and regulations. If you want to discuss an alternative approach,
10 contact the FDA staff responsible for implementing this guidance. If you cannot identify the appropriate
11 FDA staff, call the appropriate number listed on the title page of this guidance.

15 I. INTRODUCTION

17 This guidance is intended to assist sponsors who are developing drug products with the potential
18 for abuse that may need to be scheduled under the Controlled Substances Act (21 U.S.C. 811(b),
19 811(c)). Examples of products that are addressed in this guidance include new molecular entities
20 and new dosage forms of drug substances already controlled under the Controlled Substances
21 Act (21 U.S.C. 812(c)). Drugs with abuse potential generally include drugs that affect the
22 central nervous system, drugs that are chemically or pharmacologically similar to other drugs
23 with known abuse potential, and drugs that produce psychoactive effects such as sedation,
24 euphoria, or mood change.2
26 Specifically, the guidance discusses the following:
28 • The definition of abuse potential
29 • Information on submitting an abuse potential assessment, including a proposal for
30 scheduling
31 • A description of what constitutes an adequate abuse potential assessment
32 • Information for sponsors performing an assessment, including (1) the design and conduct
33 of appropriate studies and investigations and (2) general administrative recommendations
34 for submitting a proposal for scheduling
36 FDA’s guidance documents, including this guidance, do not establish legally enforceable
37 responsibilities. Instead, guidances describe the Agency’s current thinking on a topic and should
38 be viewed only as recommendations, unless specific regulatory or statutory requirements are
39 cited. The use of the word should in Agency guidances means that something is suggested or
40 recommended, but not required.

See attachments for the full pdf report
friendly
0
funny
0
informative
0
agree
0
disagree
0
like
0
dislike
0
No reactions
No reactions
No reactions
No reactions
No reactions
No reactions
No reactions
Our Discord Server invitation link is https://discord.gg/jB2qmRrxyD

Tags:
 

Related Topics

  Subject / Started by Replies Last post
0 Replies
14733 Views
Last post December 04, 2014, 04:33:25 PM
by Chip
0 Replies
14607 Views
Last post December 07, 2014, 05:22:31 PM
by Chip
0 Replies
4625 Views
Last post November 06, 2017, 08:43:21 PM
by Chip
0 Replies
4538 Views
Last post November 14, 2017, 03:17:50 AM
by Chip
0 Replies
4085 Views
Last post November 14, 2017, 03:29:02 AM
by Chip
0 Replies
4035 Views
Last post June 14, 2018, 02:20:54 PM
by Chip
2 Replies
5081 Views
Last post August 16, 2018, 01:20:53 AM
by Chip
3 Replies
6149 Views
Last post October 17, 2018, 12:05:56 AM
by Chip
0 Replies
4978 Views
Last post March 28, 2020, 06:17:41 AM
by Chip
0 Replies
2226 Views
Last post December 26, 2022, 12:12:45 AM
by Chip


dopetalk does not endorse any advertised product nor does it accept any liability for it's use or misuse





TERMS AND CONDITIONS

In no event will d&u or any person involved in creating, producing, or distributing site information be liable for any direct, indirect, incidental, punitive, special or consequential damages arising out of the use of or inability to use d&u. You agree to indemnify and hold harmless d&u, its domain founders, sponsors, maintainers, server administrators, volunteers and contributors from and against all liability, claims, damages, costs and expenses, including legal fees, that arise directly or indirectly from the use of any part of the d&u site.


TO USE THIS WEBSITE YOU MUST AGREE TO THE TERMS AND CONDITIONS ABOVE


Founded December 2014
SimplePortal 2.3.6 © 2008-2014, SimplePortal